Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Untreated Congenital Adrenal Hyperplasia can cause severe hair loss due to high androgen levels.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib is effective as a treatment for severe hair loss.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

COVID-19 can cause various skin issues, with some linked to how severe the illness is.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Iron deficiency can cause psychiatric symptoms that improve with proper treatment.

Hormonal changes and social stress may link lupus and eating disorders in teens.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib shows promise in treating severe hair loss.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.